Brief: BioRestorative Reports Compelling Preliminary Data For FDA-Fast-Tracked BRTX-100
June 13 (Reuters) - BioRestorative Therapies Inc BRTX.O: BIORESTORATIVE REPORTS COMPELLING PRELIMINARY DATA FOR FDA-FAST-TRACKED BRTX-100 – AN AUTOLOGOUS STEM CELL THERAPY TO TREAT CHRONIC LUMBAR DISC DISEASE Source text: ID:nGNX33lphM Further company coverage: BRTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM